Related Experiment Video
Updated: Oct 13, 2025

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
Convalescent plasma therapy in an immunocompromised patient with multiple COVID-19 flares: a case report
Frini Karaolidou1,2, Natasa-Eleni Loutsidi1,2, Zois Mellios1,2
1Haematology - Lymphomas Department and Bone Marrow Transplant Unit Evangelismos General Hospital Athens Greece.
Abstract:
Convalescent plasma (CP) transfusion has been utilized as a salvage therapy in immunocompromised patients with severe COVID-19 pneumonia. We describe the case of a 45-year-old immunocompromised patient, who received CP, in order to control multiple COVID-19 flares and prolonged SARS-CoV-2 viraemia lasting for 2 months after the initial diagnosis.
More Related Videos
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pericarditis III: Medical Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Myocarditis III: Medical Management
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: